Your browser version may not work well with NCBI's Web applications. More information here...
1: World J Surg. 2006 Jan;30(1):1-11.Click here to read Links

Changing treatment strategy for gastrinoma in patients with Zollinger-Ellison syndrome.

Imamura M, Komoto I, Ota S.

Department of Surgery, Osaka Saiseikai Noe Hospital, Imafuku Higashi 2-2-33, Joto-ku, Osaka, 536-0002, Japan. gbochicchio@umm.edu

We overviewed the recent development of curative surgery for gastrinoma that has been rapidly improved since the development of new localization techniques, especially the selective arterial secretagogue injection test (SASI test) and somatostatin receptor scintigraphy (SRS). A number of new pathological findings of gastrinomas in patients with Zollinger-Ellison syndrome have been accumulated in accordance with the increase of curative resection of gastrinomas, and these new findings also have contributed to the progress of the treatment strategy for grastrinomas.

PMID: 16369713 [PubMed - indexed for MEDLINE]

Patient Drug Information

  • Octreotide Injection (Sandostatin LAR® Depot, Sandostatin® )

    Your doctor has ordered octreotide to help control diarrhea and other symptoms of abdominal illness and other medical conditions such as intestinal tumors. Octreotide will be either injected subcutaneously (beneath the s...

  • Source: AHFS Consumer Medication Information